Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea. (Q37708383)
Jump to navigation
Jump to search
scientific article published on 16 March 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea. |
scientific article published on 16 March 2017 |
Statements
Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea (English)
Akito Nishida
Hiraku Akiho
Yoshihiro Nakashima
Kei Matsueda
1 reference